Autopsy report · NCT05847517

Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)

“Persistently low recruitment of subjects”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months before it started.
• Ran for about 1 year 3 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Sponsor type

Government (non-US federal)

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Interventions

Metoprolol Injection; saline 0.9%

Participants

14

Sites

12

Countries

Spain

Trials that died the same way

• Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
  “Low recruitment of participants for the study” (79% match in meaning)
• CytID Analysis of Oral Lesions
  “low subject recruitment” (76% match in meaning)
• Multifactorial Pre-operative Intervention in Diabetes Mellitus
  “Inadequate participant recruitment” (76% match in meaning)
• Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction
  “Lack of Subject Recruitment” (75% match in meaning)
• Feasibility of Home Telehealth Monitoring for Improvement in Management of Hypertension for Secondary Stroke Prevention
  “No recruitment of subjects” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.